Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Canada secures 8M additional Pfizer COVID-19 vaccine doses, CTV News says » 13:57
04/16/21
04/16
13:57
04/16/21
13:57
PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, BNTX

BioNTech

$147.00 /

+6.36 (+4.52%)

, MRNA

Moderna

$169.28 /

+9.46 (+5.92%)

Canadian Prime Minister…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$169.28 /

+9.46 (+5.92%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

Hot Stocks
U.S. exceeds 200M COVID-19 vaccine doses administered » 12:36
04/16/21
04/16
12:36
04/16/21
12:36
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$416.72 /

+0.9 (+0.22%)

, PFE

Pfizer

$38.45 /

+0.84 (+2.23%)

, BNTX

BioNTech

$151.80 /

+11.16 (+7.94%)

, MRNA

Moderna

$171.20 /

+11.38 (+7.12%)

, JNJ

Johnson & Johnson

$161.69 /

+1.19 (+0.74%)

White House COVID-19 data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
PFE Pfizer
$38.45 /

+0.84 (+2.23%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$171.20 /

+11.38 (+7.12%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
SPX S&P 500
/

+

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

  • 23
    Jul
  • 19
    May
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

Options
Merck call volume above normal and directionally bullish » 12:25
04/16/21
04/16
12:25
04/16/21
12:25
MRK

Merck

$77.30 /

+0.63 (+0.82%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$77.30 /

+0.63 (+0.82%)

MRK Merck
$77.30 /

+0.63 (+0.82%)

08:59 Today William Blair
Atea selloff on Merck update unwarranted, says William Blair
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
MRK Merck
$77.30 /

+0.63 (+0.82%)

MRK Merck
$77.30 /

+0.63 (+0.82%)

MRK Merck
$77.30 /

+0.63 (+0.82%)

MRK Merck
$77.30 /

+0.63 (+0.82%)

Hot Stocks
Sanofi completes acquisition of Kiadis Pharma » 12:01
04/16/21
04/16
12:01
04/16/21
12:01
SNY

Sanofi

$50.93 /

+0.27 (+0.53%)

, KIADF

Kiadis Pharma

$6.55 /

+ (+0.00%)

Sanofi (SNY) and Kiadis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$50.93 /

+0.27 (+0.53%)

KIADF Kiadis Pharma
$6.55 /

+ (+0.00%)

SNY Sanofi
$50.93 /

+0.27 (+0.53%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
KIADF Kiadis Pharma
$6.55 /

+ (+0.00%)

11/03/20 Canaccord
Kiadis Pharma downgraded to Hold from Buy at Canaccord
11/02/20 Piper Sandler
Kiadis Pharma downgraded to Neutral from Overweight at Piper Sandler
07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/08/20 Piper Sandler
Kiadis Pharma upgraded to Overweight from Neutral at Piper Sandler
SNY Sanofi
$50.93 /

+0.27 (+0.53%)

SNY Sanofi
$50.93 /

+0.27 (+0.53%)

SNY Sanofi
$50.93 /

+0.27 (+0.53%)

Conference/Events
Vincerx Pharma to hold a Key Opinion Leader conference call » 11:55
04/16/21
04/16
11:55
04/16/21
11:55
VINC

Vincerx Pharma

$17.85 /

-0.425 (-2.33%)

Dr. Druker of Knight…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VINC Vincerx Pharma
$17.85 /

-0.425 (-2.33%)

VINC Vincerx Pharma
$17.85 /

-0.425 (-2.33%)

01/06/21 Chardan
Vincera Pharma initiated with a Buy at Chardan
VINC Vincerx Pharma
$17.85 /

-0.425 (-2.33%)

Options
Moderna call volume above normal and directionally bullish » 11:05
04/16/21
04/16
11:05
04/16/21
11:05
MRNA

Moderna

$167.95 /

+8.13 (+5.09%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$167.95 /

+8.13 (+5.09%)

MRNA Moderna
$167.95 /

+8.13 (+5.09%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
MRNA Moderna
$167.95 /

+8.13 (+5.09%)

  • 19
    May
MRNA Moderna
$167.95 /

+8.13 (+5.09%)

MRNA Moderna
$167.95 /

+8.13 (+5.09%)

MRNA Moderna
$167.95 /

+8.13 (+5.09%)

Hot Stocks
Moderna cuts April vaccine shipment to Canada to 650,000 from 1.2M » 10:55
04/16/21
04/16
10:55
04/16/21
10:55
MRNA

Moderna

$166.61 /

+6.79 (+4.25%)

, PFE

Pfizer

$38.34 /

+0.73 (+1.94%)

Anita Anana, minister of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$38.34 /

+0.73 (+1.94%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.34 /

+0.73 (+1.94%)

04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$38.34 /

+0.73 (+1.94%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

  • 19
    May
PFE Pfizer
$38.34 /

+0.73 (+1.94%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

PFE Pfizer
$38.34 /

+0.73 (+1.94%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

PFE Pfizer
$38.34 /

+0.73 (+1.94%)

MRNA Moderna
$166.61 /

+6.79 (+4.25%)

Conference/Events
Vincerx Pharma to hold a Key Opinion Leader conference call » 10:07
04/16/21
04/16
10:07
04/16/21
10:07
VINC

Vincerx Pharma

$18.40 /

+0.125 (+0.68%)

Dr. Druker of Knight…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VINC Vincerx Pharma
$18.40 /

+0.125 (+0.68%)

VINC Vincerx Pharma
$18.40 /

+0.125 (+0.68%)

01/06/21 Chardan
Vincera Pharma initiated with a Buy at Chardan
VINC Vincerx Pharma
$18.40 /

+0.125 (+0.68%)

Initiation
Fly Intel: Top five analyst initiations » 09:55
04/16/21
04/16
09:55
04/16/21
09:55
APLS

Apellis

$46.16 /

+1.39 (+3.10%)

, DRNA

Dicerna

$29.17 /

+0.6 (+2.10%)

, EDIT

Editas Medicine

$37.35 /

-3.56 (-8.70%)

, PLMR

Palomar

$73.23 /

-0.585 (-0.79%)

, RSI

Rush Street Interactive

$14.86 /

+0.53 (+3.70%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apellis (APLS) initiated with a Buy at Goldman Sachs. 2. Dicerna (DRNA) initiated with a Buy at Goldman Sachs. 3. Editas Medicine (EDIT) initiated with a Sell at Goldman Sachs. 4. Palomar (PLMR) assumed with an Overweight at JPMorgan. 5. Rush Street Interactive (RSI) initiated with a Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

04:51 Today Goldman Sachs
Apellis initiated with a Buy at Goldman Sachs
04/14/21 Citi
Apellis year-to-date selloff brings 'very good entry point,' says Citi
03/29/21 JPMorgan
Apellis added to Analyst Focus List with $87 target at JPMorgan
01/29/21 Baird
Apellis assumed at Outperform at Baird
DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

04:53 Today Goldman Sachs
Dicerna initiated with a Buy at Goldman Sachs
03/18/21
Dicerna to hold a webinar on DCR-AUD disorder
03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

04:56 Today Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/01/21 Barclays
Editas Medicine downgraded to Equal Weight from Overweight at Barclays
PLMR Palomar
$73.23 /

-0.585 (-0.79%)

05:34 Today JMP Securities
Palomar price target lowered to $95 from $105 at JMP Securities
05:13 Today JPMorgan
Palomar assumed with an Overweight at JPMorgan
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Barclays
Palomar upgraded to Overweight from Equal Weight at Barclays
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

07:36 Today Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
05:55 Today Jefferies
Rush Street Interactive initiated with a Buy at Jefferies
04/01/21 Credit Suisse
NY online sports betting likely to make it into budget, says Credit Suisse
03/23/21 Goldman Sachs
Rush Street Interactive price target raised to $25 from $23 at Goldman Sachs
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

  • 21
    Jan
  • 24
    Jun
  • 24
    Jun
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

Periodicals
J&J reached out to vaccine rivals to study blood clot risk, WSJ reports » 09:33
04/16/21
04/16
09:33
04/16/21
09:33
JNJ

Johnson & Johnson

$160.44 /

+0.49 (+0.31%)

, PFE

Pfizer

$37.61 /

+0.45 (+1.21%)

, MRNA

Moderna

$159.85 /

-0.25 (-0.16%)

, AZN

AstraZeneca

$50.84 /

+0.97 (+1.95%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.61 /

+0.45 (+1.21%)

MRNA Moderna
$159.85 /

-0.25 (-0.16%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
PFE Pfizer
$37.61 /

+0.45 (+1.21%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
MRNA Moderna
$159.85 /

-0.25 (-0.16%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
PFE Pfizer
$37.61 /

+0.45 (+1.21%)

MRNA Moderna
$159.85 /

-0.25 (-0.16%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

  • 19
    May
PFE Pfizer
$37.61 /

+0.45 (+1.21%)

MRNA Moderna
$159.85 /

-0.25 (-0.16%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

MRNA Moderna
$159.85 /

-0.25 (-0.16%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

MRNA Moderna
$159.85 /

-0.25 (-0.16%)

JNJ Johnson & Johnson
$160.44 /

+0.49 (+0.31%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.